Works matching IS 14642662 AND DT 2016 AND VI 17 AND IP 5

Results: 13

Hospitalisation rates and associated factors in community-based cohorts of HIV-infected and -uninfected gay and bisexual men.

Published in:

HIV Medicine, 2016, v. 17, n. 5, p. 327, doi. 10.1111/hiv.12312

By:

Moore, CL;
Grulich, AE;
Prestage, G;
Gidding, HF;
Jin, F;
Mao, L;
Petoumenos, K;
Zablotska, IB;
Poynten, IM;
Law, MG;
Amin, J

Publication type:

Article

Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen.

Published in:

HIV Medicine, 2016, v. 17, n. 5, p. 385, doi. 10.1111/hiv.12313

By:

Fabbiani, M;
Zaccarelli, M;
Latini, A;
Sterrantino, G;
D'Ettorre, G;
Grima, P;
Mondi, A;
Rossetti, B;
Borchi, B;
Giuliani, M;
Antinori, A;
De Luca, A;
Di Giambenedetto, S

Publication type:

Article

Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir.

Published in:

HIV Medicine, 2016, v. 17, n. 5, p. 340, doi. 10.1111/hiv.12314

By:

Rojas, J;
Lonca, M;
Imaz, A;
Estrada, V;
Asensi, V;
Miralles, C;
Domingo, P;
Montero, M;
Rio, L;
Fontdevila, J;
Perez, I;
Cruceta, A;
Gatell, JM;
Arnedo, M;
Martínez, E

Publication type:

Article

Soluble urokinase plasminogen activator receptor (su PAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control study.

Published in:

HIV Medicine, 2016, v. 17, n. 5, p. 350, doi. 10.1111/hiv.12315

By:

Rasmussen, LJH;
Knudsen, A;
Katzenstein, TL;
Gerstoft, J;
Obel, N;
Jørgensen, NR;
Kronborg, G;
Benfield, T;
Kjær, A;
Eugen‐Olsen, J;
Lebech, A‐M

Publication type:

Article

Table of Contents.

Published in:: HIV Medicine, 2016, v. 17, n. 5, p. 317, doi. 10.1111/hiv.12332
Publication type:: Article

Editorial Board.

Published in:: HIV Medicine, 2016, v. 17, n. 5, p. 315, doi. 10.1111/hiv.12333
Publication type:: Article

Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation.

Published in:

HIV Medicine, 2016, v. 17, n. 5, p. 368, doi. 10.1111/hiv.12302

By:

Jose, S;
Quinn, K;
Dunn, D;
Cox, A;
Sabin, C;
Fidler, S;
Ainsworth, Jonathan;
Allan, Sris;
Anderson, Jane;
Babiker, Abdel;
Chadwick, David;
Delpech, Valerie;
Fisher, Martin;
Gazzard, Brian;
Gilson, Richard;
Gompels, Mark;
Hay, Phillip;
Hill, Teresa;
Johnson, Margaret;
Kegg, Stephen

Publication type:

Article

Fibroblast growth factor 23: associations with antiretroviral therapy in patients co-infected with HIV and hepatitis C.

Published in:

HIV Medicine, 2016, v. 17, n. 5, p. 373, doi. 10.1111/hiv.12305

By:

Young, J;
Mucsi, I;
Rollet‐Kurhajec, KC;
Klein, MB;
Cohen, Jeff;
Conway, Brian;
Cooper, Curtis;
Côté, Pierre;
Cox, Joseph;
Gill, John;
Haider, Shariq;
Sadr, Aida;
Johnston, Lynn;
Hull, Mark;
Montaner, Julio;
Moodie, Erica;
Pick, Neora;
Rachlis, Anita;
Rouleau, Danielle;
Sandre, Roger

Publication type:

Article

High frequency of neurosyphilis in HIV-positive patients diagnosed with early syphilis.

Published in:

HIV Medicine, 2016, v. 17, n. 5, p. 323, doi. 10.1111/hiv.12307

By:

Firlag‐Burkacka, E;
Swiecki, P;
Cielniak, I;
Siwak, E;
Gizinska, J;
Bakowska, E;
Kubicka, J;
Pulik, P;
Kowalski, J;
Podlasin, R;
Horban, A

Publication type:

Article

Influenza immunisation: knowledge and actions taken by UK HIV-positive adults.

Published in:

HIV Medicine, 2016, v. 17, n. 5, p. 397, doi. 10.1111/hiv.12309

By:

Ellis, J;
Brown, J;
Smith, C;
Snell, L;
Capocci, S;
Ferro, F;
Ferreira, J;
Marshall, N;
Webster, D;
Johnson, M;
Lipman, M

Publication type:

Article

Switching from a two-tablet regimen of tenofovir/emtricitabine and efavirenz to a one-tablet regimen may affect patients' perceptions and drug management.

Published in:

HIV Medicine, 2016, v. 17, n. 5, p. 390, doi. 10.1111/hiv.12345

By:

Rotzinger, A;
Locatelli, I;
Bugnon, O;
Fayet Mello, A;
Parienti, J‐J;
Cavassini, M;
Schneider, M.P

Publication type:

Article

Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials.

Published in:

HIV Medicine, 2016, v. 17, n. 5, p. 358, doi. 10.1111/hiv.12348

By:

Arribas, JR;
Girard, P‐M;
Paton, N;
Winston, A;
Marcelin, A‐G;
Elbirt, D;
Hill, A;
Hadacek, MB

Publication type:

Article

Comparative risk of failure of ABC/3 TC or TDF/ FTC based first-line regimens in patients with a high viral load.

Published in:

HIV Medicine, 2016, v. 17, n. 5, p. 380, doi. 10.1111/hiv.12306

By:

Flandre, P;
Pugliese, P;
Allavena, C;
Katlama, C;
Cotte, L;
Cheret, A;
Cabié, A;
Rey, D;
Chirouze, C;
Bani‐Sadr, F;
Cuzin, L;
Enel, P.;
Obry‐Roguet, V.;
Faucher, O.;
Bregigeon, S.;
Poizot‐Martin, I.;
Marchou, B.;
Massip, P.;
Bonnet, E.;
Obadia, M.

Publication type:

Article